Skip to main content

Feanalytic has received major funding and support from Novo Nordisk Foundation, Business Finland, and SPARK Finland. We are a part of the InFLAMES Research Flagship. Through these partnerships, Feanalytic aims to expedite the integration of its technology toward clinical practice, revolutionizing the diagnosis and treatment of IBD worldwide.